PALISADE BIO INC (PALI) Stock Balance Sheet
NASDAQ:PALI • US6963894026
Current stock price
1.8 USD
-0.18 (-9.09%)
Last:
| MRQ (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 5.42M | 9.82M | 12.43M | 12.38M | 10.49M | |||
| Marketable Securities | N/A | N/A | N/A | N/A | N/A | |||
| Receivables | 6.00K | 24.00K | 148.00K | 1.44M | 150.00K | |||
| Other Current Assets | 1.02M | 649.00K | 748.00K | 912.00K | 861.00K | |||
| Total Current Assets | 6.45M | 10.49M | 13.33M | 14.73M | 11.51M | |||
| Non-Current Assets | ||||||||
| PPE Net | 23.00K | 87.00K | 208.00K | 310.00K | 112.00K | |||
| Intangibles | N/A | N/A | N/A | N/A | N/A | |||
| Other Non-Current Assets | 197.00K | 299.00K | 516.00K | 720.00K | 894.00K | |||
| Total Non-Current Assets | 220.00K | 386.00K | 724.00K | 1.03M | 1.01M | |||
| TOTAL ASSETS | 6.67M | 10.88M | 14.05M | 15.76M | 12.51M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 314.00K | 79.00K | 158.00K | 88.00K | 87.00K | |||
| Accrued Expenses | 2.28M | 2.05M | 1.73M | 1.17M | 1.09M | |||
| Accounts Payable | 1.37M | 1.10M | 698.00K | 1.76M | 1.32M | |||
| Other Current Liabilities | N/A | N/A | N/A | N/A | N/A | |||
| Total Current Liabilities | 3.97M | 3.24M | 2.59M | 3.01M | 2.50M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 77.00K | 152.00K | 153.00K | 272.00K | 2.65M | |||
| Total Non-Current Liabilities | 77.00K | 152.00K | 153.00K | 272.00K | 2.65M | |||
| TOTAL LIABILITIES | 4.05M | 3.39M | 2.74M | 3.28M | 5.15M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -140.96M | -135.94M | -121.51M | -109.19M | -94.64M | |||
| Additional Paid In Capital | 143.53M | 143.41M | 132.72M | 121.64M | 102.00M | |||
| Common Shares | 50.00K | 29.00K | 95.00K | 32.00K | 5.00K | |||
| Other Shareholders' Equity | N/A | N/A | N/A | N/A | N/A | |||
| Shares Outstanding | 4.80M | 2.77M | 618.00K | 196.00K | 19.00K | |||
| Tangible Book Value per Share | 0.55 | 2.71 | 18.30 | 63.66 | 387.53 | |||
| Total Shareholders' Equity | 2.62M | 7.49M | 11.31M | 12.48M | 7.37M | |||
| TOTAL LIABILITIES AND EQUITY | 6.67M | 10.88M | 14.05M | 15.76M | 12.51M | |||
| Statistics | ||||||||
| Current Ratio | 1.62 | 3.24 | 5.15 | 4.89 | 4.61 | |||
| Return On Assets (ROA) | -177.67% | -132.70% | -87.53% | -90.47% | -212.72% | |||
| Return On Equity (ROE) | -452.10% | -192.71% | -108.72% | -114.27% | -361.38% | |||
All data in USD , ROIC based on taxRate of 0.21